1. Journal searcher
  2. Top 15 journals in Neurology (clinical)
  3. Frontiers in Clinical Drug Research - Alzheimer Disorders
Default: Frontiers in Clinical Drug Research - Alzheimer Disorders

ISSN: 2214-5168

Journal Home

Journal Guideline

Frontiers in Clinical Drug Research - Alzheimer Disorders Q2 Unclaimed

Bentham Science Publishers B.V. Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series indexed in SJR in Neurology (clinical) and Psychiatry and Mental Health with an H index of 3. It has an SJR impact factor of 0,423 and it has a best quartile of Q2. It has an SJR impact factor of 0,423.

Type: Book series

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q2) Neurology (clinical) (Q3) Pharmacology (medical) (Q3) Psychiatry and Mental Health (Q3)
Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Frontiers in Clinical Drug Research - Alzheimer Disorders

0,423

SJR Impact factor

3

H Index

0

Total Docs (Last Year)

7

Total Docs (3 years)

0

Total Refs

7

Total Cites (3 years)

1

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!
User post comment
* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Neural Plasticity Q2
CNS Spectrums Q2
Journal of Geriatric Psychiatry and Neurology Q2
Neurology International Q2
Journal of Neuromuscular Diseases Q2
Compare this journals

Aims and Scope

FAQS

What is the impact factor of Frontiers in Clinical Drug Research - Alzheimer Disorders?

In Country of Paypers you can find Impact factor and other metrics to help you decide on a Journal.